INDEGENE
Back to Income Statement
|
INDEGENE Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹534 Cr | ₹505 Cr | ₹396 Cr | ₹287 Cr | ₹231 Cr |
What is the latest Operating Profit of INDEGENE ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹534 Cr |
| Mar2024 | ₹505 Cr |
| Mar2023 | ₹396 Cr |
| Mar2022 | ₹287 Cr |
| Mar2021 | ₹231 Cr |
How is Operating Profit of INDEGENE Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹534 Cr | 5.72 | |
| Mar2024 | ₹505 Cr | 27.66 | |
| Mar2023 | ₹396 Cr | 37.98 | |
| Mar2022 | ₹287 Cr | 24.46 | |
| Mar2021 | ₹231 Cr | - | |
Compare Operating Profit of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹10,595.2 Cr | 1% | -11.4% | -15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 1% |
-11.4% |
-15% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses